TY  - GEN
AU  - Thel,M C
AU  - Califf,R M
AU  - Tardiff,B E
AU  - Gardner,L H
AU  - Sigmon,K N
AU  - Lincoff,A M
AU  - Topol,E J
AU  - Kitt,M M
AU  - Blankenship,J C
AU  - Tcheng,J E
TI  - Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis
SN  - 0002-9149
PY  - 2000///0331
KW  - Aged
KW  - Angina, Unstable
KW  - mortality
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Coronary Thrombosis
KW  - Electrocardiography
KW  - Eptifibatide
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - etiology
KW  - Peptides
KW  - administration & dosage
KW  - Platelet Aggregation Inhibitors
KW  - Prospective Studies
KW  - Risk Factors
KW  - Secondary Prevention
KW  - Survival Rate
KW  - Thrombolytic Therapy
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - epidemiology
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1016/s0002-9149(99)00767-5
ER  -